Clinical Trials Browser

NCT05037149 2024-03-18

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

Phase 1 Unknown

50 enrolled

Other solid neoplasm

Solid Tumor

NCT06164327 2023-12-11

Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Phase 1 Unknown

75 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04190823 2023-11-27

A Study of RC98 in Subjects With Advanced Malignant Solid Tumors

Phase 1 Unknown

63 enrolled

Other solid neoplasm

Solid Tumors

NCT06059508 2023-11-07

Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors

Phase 1 Unknown

100 enrolled

Advanced Malignant Tumor

NCT06116240 2023-11-03

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

Phase 1 Unknown

135 enrolled

Other solid neoplasm

Solid Tumor

NCT05755854 2023-09-22

Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors

Phase 1 Unknown

10 enrolled

Hematologic Diseases

NCT03709914 2023-09-15

Pediatric_PK

Phase 1 Unknown

21 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06008405 2023-09-06

Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy

Phase 1 Unknown

48 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05957471 2023-07-24

BC3195

Phase 1 Unknown

27 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT05867563 2023-07-10

Clinical Trial Evaluating the Safety of the TQB2103 for Injection

Phase 1 Unknown

71 enrolled

Other neoplasm

Advanced Malignant Neoplasm

NCT05856630 2023-05-12

Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg

Phase 1 Unknown

24 enrolled

Genitourinary

Prostatic Neoplasms

NCT05438394 2023-04-14

Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM

Phase 1 Unknown

24 enrolled

Plasma cell

Multiple Myeloma

NCT04787003 2023-03-23

Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors

Phase 1 Unknown

50 enrolled

Tumor-Agnostic

Neoplasms

NCT05405621 2022-10-27

Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009

Phase 1 Unknown

48 enrolled

Other solid neoplasm

Locally Advanced/Metastatic Solid Tumours

NCT05508620 2022-08-23

A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors

Phase 1 Unknown

270 enrolled

Other solid neoplasm

Malignant Solid Tumors

NCT05475847 2022-07-28

TIL

Phase 1 Unknown

20 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05198817 2022-06-28

A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients

Phase 1 Unknown

240 enrolled

Advanced Malignant Tumors

NCT05429398 2022-06-23

A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor

Phase 1 Unknown

118 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04604691 2022-03-08

Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD)

Phase 1 Unknown

20 enrolled

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05052970 2022-02-01

Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MM

Phase 1 Unknown

60 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT04811118 2022-01-31

The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere

Phase 1 Unknown

27 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05125523 2022-01-25

A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors

Phase 1 Unknown

264 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT04282070 2021-12-21

SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 1 Unknown

91 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05009966 2021-10-25

Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor

Phase 1 Unknown

272 enrolled

Gastrointestinal

Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT05070221 2021-10-07

Study of Oncolytic Virus in Combination With HX-008 and Axitinib in Melanoma Patients With Liver Metastasis

Phase 1 Unknown

30 enrolled

Dermatologic

Melanoma

NCT05068453 2021-10-05

Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis

Phase 1 Unknown

15 enrolled

Dermatologic

Melanoma

NCT04173676 2021-02-24

Sentinel Lymph Node Navigation Surgery Using Near-infrared Imaging in Early Esophageal Cancer

Phase 1 Unknown

84 enrolled

Detection Rate of SLN ; Accuracy Rate of Lymph Node Metastasis

NCT04673396 2020-12-21

Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor

Phase 1 Unknown

36 enrolled

Other solid neoplasm

Solid Tumor

NCT04625894 2020-11-12

The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in Oligometastatic Gastrointestinal Cancer

Phase 1 Unknown

21 enrolled

Gastrointestinal

Oligometastatic Gastrointestinal Cancer

NCT04169178 2020-05-01

Evaluate Safety, Tolerability and PK of HLX55 in Patients With Advanced Solid Tumors With Different cMET Status

Phase 1 Unknown

98 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT04189211 2019-12-06

A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients

Phase 1 Unknown

30 enrolled

Other solid neoplasm

HER2-Positive Solid Tumors

NCT02066870 2015-03-13

Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI

Phase 1 Unknown

9 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung